Transactions
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-09 | EQT AB | Gustav Segerberg | Other senior executive | Conversion increase | 10 403 | 242,79 | SEK | 2 525 744,37 | 2024-03-07 |
| 2024-03-09 | EQT AB | Gustav Segerberg | Other senior executive | Conversion decrease | 10 403 | 0 | SEK | 0 | 2024-03-07 |
| 2024-03-09 | EQT AB | Kim Christian Henriksson | Chief Financial Officer (CFO) | Conversion increase | 5 201 | 242,79 | SEK | 1 262 750,79 | 2024-03-07 |
| 2024-03-09 | EQT AB | Kim Christian Henriksson | Chief Financial Officer (CFO) | Conversion decrease | 5 201 | 0 | SEK | 0 | 2024-03-07 |
| 2024-03-09 | Scandi Standard AB (publ) | Cecilia Lannebo | Member of the Board of Directors | Acquisition | 3 339 | 66 | SEK | 220 374 | 2024-03-07 |
| 2024-03-09 | Iconovo AB | Färna Invest AB | Other senior executive | Subscription | 1 250 000 | 8 | SEK | 10 000 000 | 2024-03-07 |
| 2024-03-09 | Elicera Therapeutics AB | Jan Zetterberg | Member of the Board of Directors | Subscription | 10 000 | 16,2 | SEK | 162 000 | 2024-03-07 |
| 2024-03-09 | Elicera Therapeutics AB | Jan Zetterberg | Member of the Board of Directors | Subscription | 4 300 | 16,2 | SEK | 69 660 | 2024-03-07 |
| 2024-03-09 | Elicera Therapeutics AB | Christina Herder | Member of the Board of Directors | Subscription | 3 100 | 16,2 | SEK | 50 220 | 2024-03-07 |
| 2024-03-09 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Disposal | 500 000 | 0,002 | SEK | 1 200 | 2024-02-29 |
| 2024-03-09 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Disposal | 1 687 000 | 0,002 | SEK | 2 682,33 | 2024-03-03 |
| 2024-03-09 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 31 000 | 0,005 | SEK | 158,1 | 2024-03-03 |
| 2024-03-09 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 64 500 | 0,018 | SEK | 1 180,35 | 2024-02-25 |
| 2024-03-09 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Subscription | 21 700 | 16,2 | SEK | 351 540 | 2024-03-07 |
| 2024-03-10 | Elicera Therapeutics AB | Margareth Jorvid | Member of the Board of Directors | Subscription | 3 100 | 16,2 | SEK | 50 220 | 2024-03-07 |
| 2024-03-09 | PION Group AB | Nils Karlsson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 14 880 | 6,72 | SEK | 99 993,6 | 2024-03-07 |
| 2024-03-09 | Nelly Group AB (publ) | Niklas Lingblom | Chief Financial Officer (CFO) | Acquisition | 6 500 | 16,036 | SEK | 104 231,101 | 2024-03-07 |
| 2024-03-09 | Nelly Group AB (publ) | Niklas Lingblom | Chief Financial Officer (CFO) | Acquisition | 5 170 | 16,105 | SEK | 83 260,798 | 2024-03-07 |
| 2024-03-09 | Bio-Works Technologies AB | Karsten Erik Andreas Fjärstedt | Deputy CEO/Deputy Managing Director | Acquisition | 12 400 | 4,79 | SEK | 59 396 | 2024-03-07 |
| 2024-03-10 | Cantor Fitzgerald Ireland Limited | Anne Dorney | Member of the Board of Directors | Acquisition | 37 000 | 11,539 | SEK | 426 952,25 | 2024-03-06 |